British drugmaker AstraZeneca on Thursday posted soaring net profit in the first quarter as significant one-off costs were not repeated. Robust sales of cancer treatments, offsetting a slump in demand for Covid-related treatments, helped also to boost profits after tax. Net earnings leapt almost five-fold to $1.8 billion (1.6 billion euros) in the three months…

AstraZeneca's Evusheld drug has been recommended for marketing in the European Union to treat patients at risk of death from Covid, the British pharmaceutical group said Friday.

World Health Organisation (WHO), yesterday, offered an explanation why healthy life expectancy in the African region increased on average by 10 years per person between 2000 and 2019.

Covid-vaccine maker AstraZeneca said Friday that profits fell sharply in the first half on ballooning costs linked to its takeover of US biotech firm Alexion.

Scientists have made recommendations on how Nigeria can match the United States (U.S.), United Kingdom (U.K.), China and Japan in development of Science and Technology.

The world's largest vaccine maker, the Serum Institute of India, has halted production of the locally made version of the AstraZeneca Covid-19 vaccine due to falling demand, its chief executive said Friday.

As Nigeria marks the one-year anniversary of the first shipment of COVID-19 vaccines to the country today through the COVAX facility, efforts are being made to ensure

British pharmaceutical giant AstraZeneca said Thursday that a third, or "booster", dose of its Covid-19 vaccine Vaxzevria "significantly" lifted antibody levels against the Omicron strain in a laboratory study.

Minister of Health, Dr Osagie Ehanire has reacted to media reports alleging that about 1 million doses of AstraZeneca COVID-19 vaccine expired in Nigeria last month.

British pharmaceutical giant AstraZeneca, which is selling its Covid vaccine at cost price, said Friday that it had fallen into a loss in the third quarter.

British pharmaceuticals giant AstraZeneca on Monday revealed more positive results from a trial of a treatment for Covid-19 symptoms. The drug, made from a combination of two antibodies, achieved a "statistically significant reduction in severe Covid-19 or death" in non-hospitalised patients with mild-to-moderate symptoms, AstraZeneca said in a statement. The group's treatment, known as AZD7442,…

The Ekiti State Government has debunked the rumour that some COVID-19 vaccines are spoilt due to the lack of electricity supply in the state.